- Home
- GOSS vs MPV Comparison
GOSS vs MPV Comparison
Compare GOSS & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- MPV
- Stock Information
- Founded
- GOSS 2015
- MPV 1988
- Country
- GOSS United States
- MPV United States
- Employees
- GOSS N/A
- MPV N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- GOSS Health Care
- MPV Finance
- Exchange
- GOSS Nasdaq
- MPV Nasdaq
- Market Cap
- GOSS 203.3M
- MPV 183.8M
- IPO Year
- GOSS 2019
- MPV N/A
- Fundamental
- Price
- GOSS $1.12
- MPV $17.15
- Analyst Decision
- GOSS Strong Buy
- MPV
- Analyst Count
- GOSS 4
- MPV 0
- Target Price
- GOSS $7.50
- MPV N/A
- AVG Volume (30 Days)
- GOSS 1.6M
- MPV 25.2K
- Earning Date
- GOSS 05-13-2025
- MPV 01-01-0001
- Dividend Yield
- GOSS N/A
- MPV 8.71%
- EPS Growth
- GOSS N/A
- MPV N/A
- EPS
- GOSS N/A
- MPV 1.71
- Revenue
- GOSS $114,701,000.00
- MPV N/A
- Revenue This Year
- GOSS N/A
- MPV N/A
- Revenue Next Year
- GOSS $172.31
- MPV N/A
- P/E Ratio
- GOSS N/A
- MPV $9.35
- Revenue Growth
- GOSS N/A
- MPV N/A
- 52 Week Low
- GOSS $0.50
- MPV $11.18
- 52 Week High
- GOSS $1.55
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- GOSS 56.55
- MPV 55.85
- Support Level
- GOSS $1.06
- MPV $16.52
- Resistance Level
- GOSS $1.26
- MPV $17.45
- Average True Range (ATR)
- GOSS 0.11
- MPV 0.34
- MACD
- GOSS 0.04
- MPV -0.01
- Stochastic Oscillator
- GOSS 70.09
- MPV 67.74
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.